Nestle raises stake in food allergy drug developer Aimmune Medical Dialogues Bureau13 Nov 2018 3:53 PM ISTThe health science arm of Nestle SA will pay $98 million to raise its stake in Aimmune Therapeutics Inc, the drug developer said, as it prepares to...
Lupin gets USFDA nod for Asthma drug Medical Dialogues Bureau13 Nov 2018 3:53 PM ISTNew Delhi: Drug major Lupin Tuesday said it has received approval from the US health regulator to market Budesonide Inhalation Suspension single-dose...
Cipla gets USFDA nod for anti-viral eye infection drug for AIDS patients Medical Dialogues Bureau13 Nov 2018 3:53 PM ISTDrug major Cipla Monday said it has received final approval from the US health regulator for Valganciclovir tablets, used in the treatment of viral...
Zydus Cadila gets USFDA nod for Anti-Fungal Ointment Medical Dialogues Bureau13 Nov 2018 3:43 PM ISTNew Delhi: Zydus Cadila said it has received final approval from the US health regulator to market Nystatin and Triamcinolone Acetonide Ointment, used...
China mulls USD 720,000 fine for faking vaccine tests after scandal Medical Dialogues Bureau13 Nov 2018 9:42 AM ISTBeijing: Chinese vaccine manufacturers who falsify test results or break other rules could be fined up to USD 720,000 under a new law proposed after a...
Takeda sets vote date, aims to close $62 Billion Shire deal Jan. 8 Medical Dialogues Bureau13 Nov 2018 9:00 AM ISTLONDON: Japan's Takeda Pharmaceutical will hold an investor vote on its $62 billion acquisition of Shire next month and aims to close the deal on Jan....
New DRUG options, risk factors added to AHA Heart guidelines, details Medical Dialogues Bureau12 Nov 2018 3:41 PM ISTHigher risk patients are advised to first try statins in combination with ezetimibe, the generic version of Zetia, which lowers cholesterol by...
Cipla gets USFDA nod for generic version of Voltran Gel Medical Dialogues Bureau12 Nov 2018 11:47 AM ISTNew Delhi: Drug major Cipla has received final approval from the United States Food and Drug Administration (USFDA) for, indicated for the relief of...
Wockhardt Q2 net loss widens to Rs 23 Crore Medical Dialogues Bureau12 Nov 2018 11:05 AM ISTIndia business stood at Rs 455 crore in the quarter as against Rs 452 crore in the same period last year. It contributed 40 per cent of the global...
USFDA completes inspection of Biocon Bengaluru plant with no observations Medical Dialogues Bureau12 Nov 2018 10:20 AM ISTZero ObservationNew Delhi: Biotechnology major Biocon has announced the US health regulator has completed the inspection of its new manufacturing...
AstraZeneca's Diabetic drug Farxiga curbs heart failure, kidney risks Medical Dialogues Bureau12 Nov 2018 9:15 AM ISTNew Delhi: The biggest clinical trial so far to assess a new class of diabetes pills shows that AstraZeneca's Farxiga can prevent heart failure and...
NPPA fixes ceiling price of Volini Max gel Medical Dialogues Bureau11 Nov 2018 11:55 AM ISTNew Delhi: Through a recent notice, National Pharmaceutical Pricing Authority (NPPA), has fixed the price of various formulations of Volini Maxx...
